# Shenzhen Keruida Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-keruida-biotechnology-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.corestarbio.com
- Latest round: Series A (Jun 28, 2022)
- Investors on record: 1

## About

Established in 2017 and based in Shenzhen, China, Shenzhen Keruida Biotechnology Co., Ltd is a medical device company specializing in the development, production and sales of POCT (Point-of-Care Testing) equipment. In June 2022, Shenzhen Keruida Biotechnology Co., Ltd raised an undisclosed amount of series A funding from new investor IDG Capital. The company has a class 100,000 cleanroom and more than ten microfluidic chip and chemiluminescence independent research and development patents.

The company's self-developed products include microfluidic chemiluminescence immunoassay CORESTAR-100, diagnostic reagents such as cardiac fatty acid binding protein assay kit, follicle stimulating hormone reagent, calcitoninogen reagent.

The company plans to use the series A funding for R&D lab construction, new product pipeline expansion and team expansion.

## Funding rounds

- Series A, Jun 28, 2022 — IDG Capital

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A